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Since the National Advisory Committee on Drugs
(NACD) was established in July 2000 it has
sought, through its three-year work programme,
to address gaps in our knowledge of drug misuse
in an Irish context. The work of the NACD
continues to increase the amount of available
research which will in turn facilitate greater
evidence-based policy making in the difficult and
complex area of problem drug use in Ireland.
In this context, I am happy to welcome this new
overview of cocaine use in Ireland. Over the last
number of years, the Government has become
aware of an increase in the use of cocaine in
Ireland. This trend would appear to coincide with
an increase in the availability and use of cocaine
in Europe generally and a consequential drop in
the street price. In addition, it appears that there
is a growing perception among users that
cocaine is a ‘safe drug’. However, the risks
associated with the drug are extremely high,
particularly when combined with alcohol and this
is a message that needs to be highlighted.
Misuse of drugs remains one of the major social
problems facing Irish society today and the
Government will continue to work in partnership
with communities most affected by the problem.
Implementing the 100 actions in the National
Drugs Strategy 2001-2008 and initiatives such as
the Local and Regional Drugs Task Forces remain
a priority for Government.
Finally, I would like to record my appreciation of
the on-going work of all of the members of the
National Advisory Committee on Drugs, in
particular, its Chairperson - Dr. Des Corrigan, its
Director - Ms. Mairéad Lyons and its Research
Officer - Ms. Aileen O’Gorman.
Noel Ahern T.D.
Minister of State with responsibility for the
National Drug Strategy
Foreword, Minister of State
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This overview of cocaine use in Ireland illustrates
the diversity of the work of the NACD and its
staff because it includes all of the elements of 
the NACD’s mandate which is to advise the
Government on the prevalence, prevention,
treatment and consequences of problem drug
use in Ireland. 
As a result of reports indicating increased levels 
of cocaine use in Ireland, the NACD has published
this report to provide baseline information on
cocaine and its use in Ireland. It represents a
significant effort by many agencies and individuals
who contributed information and data for the
report and my colleagues and I are enormously
grateful to them for their help and their willingness
to share information with us. 
The report indicates several areas of concern
especially relating to the injection of cocaine 
by some users and also highlights gaps in our
knowledge of the implications of so-called
recreational use of cocaine powder by the 
nasal route on an occasional or regular basis. 
In addition, the challenge to the prevention
networks and the treatment services of
incorporating another drug with serious social,
personal and health consequences into their 
case mix should not be underestimated. It is our
hope that this overview will provide a basis for 
a consideration of how best to respond to the
many issues which arise from the increasing use
of this drug, which has effects unique to it as a
psychostimulant but which simultaneously poses
risks which are common to mood altering drugs
in general. 
In presenting this report for consideration by 
all those involved in responding to the drugs
phenomena I, on behalf of the NACD, would like
to record our appreciation of the hard work by
the Director of the NACD, Ms Mairéad Lyons and
by our Research Officer, Ms Aileen O’Gorman,
which has made its timely publication possible. 
Dr Desmond Corrigan
Chairperson
NACD
Foreword, Chairperson, NACD
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Prevalence Survey Data
 The NACD & DAIRU (2003) drug prevalence
survey results show 3% of the general adult
population report ever using cocaine and less
than one per cent report ever using crack. 
Lifetime prevalence was highest among 
15-24 year olds at 5.1%.
 The SLÁN (2002) survey reported an increase
in levels of cocaine use. Last year use by males
increased from 1.8% in 1998 to 3.0% in 2002
and in females from 0.6% to 1.9% during the
same period.
 The ESPAD (1999) survey reported lifetime use
of cocaine and crack at 2% among 16 year old
school children.
 The HBSC (1998) survey reported 2.3% of the
10-17 year old respondents ever using cocaine,
with 1.7% using in the previous month.
Police and Criminal Justice Data
 Offences relating to cocaine have almost
doubled from 1999 to 2001, however, cocaine
related offences represent only 3% of all
offences under the Misuse of Drugs Act.
 Cocaine related offences were recorded
predominantly in the Dublin Metropolitan
Region (62%) with a notable number (17%)
recorded in the Southern Region. 
 Seizures of cocaine remain consistent at 3% of
the total number of seizures.
Laboratory Data
 Substantial increases have been reported 
in urine samples testing positive for cocaine
among the drug treatment population 
since 2000.
 The Medical Bureau of Road Safety report
small numbers of samples testing positive 
for cocaine.
Drug Treatment Data
 The number of clients who report cocaine 
as their main problem drug has remained
consistently small – approximately 1% of 
all those in drug treatment.
 The numbers reporting cocaine as their
secondary problem drug have increased since
1996. However, benzodiazepines remain the
most frequently reported secondary drugs.
 Primary cocaine users in treatment were
predominantly snorting cocaine while over 
half of those presenting with cocaine as their
secondary drug were injecting cocaine.
 The majority of treatment contacts reporting
the use of cocaine were from the ERHA
region, however, a small number of clients 
with cocaine problems had received treatment
outside of the ERHA area. 
Research Studies of Cocaine Use
Mayock (2001) – Exploratory Study 
of Cocaine Use in Ireland
 The findings of this study strongly suggest 
an increased availability and use of cocaine,
especially among certain groups of recreational
poly drug users and an increased visibility of
cocaine on the club and pub scenes.
 Signs of increased cocaine use among opiate
users in disadvantaged areas of Dublin were
also noted.
 The study indicated that the nature of cocaine
use is likely to differ substantially between
problematic opiate drug users and
recreational drug users.
UISCE (2002) – Survey of Cocaine Users
 A survey of 100 cocaine/crack users reported
high levels of use mostly administered by
injection and snorting. Poly drug use was
common, mostly involving alcohol and cannabis
but with notable levels of benzodiazepine and
heroin use. 
Key Indicators of Cocaine Use
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 Almost half of the respondents said they were
currently receiving drug treatment for their
problem heroin use.
 Well over half of the respondents felt their
cocaine use was problematic, more than half
of these had sought information on using
cocaine, however, less than a third of these
had sought treatment.
Merchants Quay Ireland (2003) –
Survey of Cocaine Users
 A survey of 100 cocaine/crack users found high
levels of poly drug use in the group with the
vast majority using a range of drugs including
heroin, benzodiazepines and alcohol.
 The majority of the respondents reported heroin
as their primary drug of use, with a smaller
number reporting cocaine as their primary drug.
 The vast majority reported injecting cocaine,
with a high proportion reporting injecting a
mixture of cocaine and heroin – a speedball.
 Few of the respondents viewed their cocaine
use as problematic and only a small proportion
had sought treatment for their cocaine use.
However, most of those surveyed were
currently on methadone maintenance
programmes. 
Anecdotal Information
 Anecdotal reports suggest that the increase 
in cocaine use has been across the general
population not just among existing problem
drug users or confined to certain urban areas.
 New cocaine users perceived the drug as
clean and acceptable with minimal health
implications, and were attracted by the
perceived effects such as the absence of
hangovers and an increased sex drive.
 Reports indicate that cocaine powder is being
sold for between €30-40 per ‘1/2 gram’
(usually a smaller amount is involved) and 
a rock of crack cocaine for €50. 
Treatment Approaches
 There is no substitute drug available to treat
cocaine dependence.
 Comprehensive programmes which include
drug counselling, cognitive behavioural
therapy as well as social and vocational
interventions were found to be effective.
 In summary, our review of treatment literature
found the following to be effective:
 Some combined pharmacotherapies in
conjunction with other interventions
 Individual drug counselling
 Group therapy/counselling
 Self help groups
 Peer leadership
 Provision of early appointments
 Outpatient programme for moderate
problems
 Residential programme for complex and
severe problems
In addition, Auricular Acupuncture is showing
promise in the management of cocaine
dependence.
Findings and Implications
 Drug prevention approaches in Ireland are
consistent with best practice internationally
and there should be continued investment 
in this area.
 The perception that cocaine is a safe drug
needs to be addressed given the levels of 
risk behaviour associated with injecting, with
sharing of snorting and smoking equipment,
and with combining cocaine use with alcohol
and other drugs.
 The regional spread of cocaine users in both
treatment data and Garda Síochána data
indicates that the use of cocaine is not just 
a Dublin phenomenon.
 Evidence suggests that primary cocaine 
users do not perceive themselves as requiring
treatment for their drug use, or, that they
perceive existing treatment services as being
inappropriate to their needs.
 The level of poly drug use noted in both 
the treatment population and the surveys of
cocaine users represents a challenge for drug
education, prevention, treatment, and harm
reduction services. 
 For drug treatment services the challenge 
will be to turn what has historically been a
predominantly opiate focused system into 
one that meets the needs of cocaine and 
other drug users. Without the incentive of 
a substitute drug to offer, such as methadone,
a key task will be to attract problem cocaine
users into services and retain them long
enough to achieve lasting change.
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1.1 The Drug
Cocaine hydrochloride is a stimulant derived from
the leaves of the coca bush which grows primarily
in the South American counties of Columbia,
Peru and Bolivia. In Ireland, the drug is available
in two forms cocaine powder (hydrochloride salt)
and crack (freebase). Cocaine powder is usually
administered by snorting through the nose using
a rolled up banknote, straw etc., although it is
also known to be taken orally and smoked.
Cocaine may also be made into a solution and
injected either on its own or in combination with
heroin (known as a ‘speedball’). Crack, or
freebase, is produced by ‘washing’ the salt with
ammonia or mixing it with sodium bicarbonate,
and is so called due to the cracking sounds the
‘rocks’ make when smoked in a pipe.
1.2 Legislation
Cocaine is controlled in Ireland under the Misuse
of Drugs Act (MDA). The leaf is covered under
Schedule 1 as it has no recognised medical use,
consequently a licence may be granted by the
Minister for Health for research and analysis
purposes. Cocaine and its salts are covered
under Schedule 2, this makes it illegal to
produce, possess or supply the drug except on
prescription. It is also illegal to allow premises to
be used for production or supply.1
1.3 The Effects and Risks
The drug takes effect within minutes and users
tend to feel energetic, alert, euphoric and
talkative, with heightened sensations of sight,
sound and smell. The effects from snorting
cocaine start quickly but only last for up to 30
minutes without repeating the dose. The effects
come on more rapidly if the user is smoking crack
cocaine but these are then more short lived,
approximately 10 minutes.2
When cocaine is taken with alcohol it combines in
the system to form another drug – cocaethylene –
which is more toxic than using either drug alone3. 
Cocaine can produce severe psychological
dependence because of the strong cravings it
produces leading to compulsive patterns of use.
Tolerance develops resulting in users taking
larger and/or more frequent doses in order to
maintain the high.4
Common physical effects include dry mouth,
sweating, loss of appetite and increased heart
and pulse rate. Users may experience headaches,
stomach pains and nausea, tremors, irritability,
paranoia and hallucinations. Cocaine affects heart
rhythms leading to possible heart attacks, it can
lead to chest pain, raised blood pressure,
respiratory failure, strokes and seizures.5
The after-effects of using cocaine and crack 
may include fatigue and depression as people
come down from the high. Restlessness, nausea,
hyperactivity, insomnia and weight loss may
develop with frequent use. Lack of sleep and
weight loss may lead to exhaustion and the user
becoming very run down.6
Chronic use or heavy binges can lead to the
development of paranoia, hallucinations, anxiety
with panic attacks, and agitation. Confusion and
aggressive behaviour may develop and violent
behaviour may ensue.7
Prolonged heavy use of cocaine is usually
followed by a ‘crash’ if use is discontinued. This
‘crash’ is characterised by exhaustion, restless
sleep patterns, insomnia and depression.8
Repeated snorting of cocaine damages the
membranes which line the nose. Repeated
smoking of crack may cause breathing problems
and partial loss of voice. Long term injecting may
result in abscesses and infection. Injectors risk
hepatitis and HIV infection if injecting equipment
is shared. The sharing of smoking and snorting
equipment has also risks for Hepatitis C.9
Cocaine users may be at increased risk of sexual
transmission of HIV and Hepatitis B (and other
sexually transmitted diseases) due to increased
sexual risk behaviours and an association of
stimulant use with sex work.10
Pregnant users of cocaine or crack may
experience complications and find that their
babies are adversely affected.11
About Cocaine
Chapter 1
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9For both crack and cocaine, dependency is not
inevitable. Whether people become dependent,
and if so how quickly it happens, will vary
depending on the individual user’s mental state
and circumstances.12
The fact that cocaine and crack are expensive
means that people who become heavy or
dependent users may spend vast amounts of
money and may find themselves involved in
crime or prostitution to fund their habit. 
1 Corrigan, 2003
2 Drugscope, 2003
3 Corrigan, 2003
4 Drugscope, 2003
5 Advisory Council on the Misuse of Drugs (ACMD), 2000;
Scottish Advisory Committee on Drug Misuse (SACDM),
2002 
6 Drugscope, 2003
7 SACDM, 2002
8 Erickson et al., 1987
9 Frischer, 1993; SACDM, 2002
10 National Treatment Agency, 2002
11 SACDM, 2002
12 Ditton and Hammersley, 1996; Reinarman, Murphy &
Waldorf , 1994
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As with other illicit drugs, it is difficult to calculate
the extent of cocaine use within the population.
Consequently, we must assess information from 
a range of sources to give us an indication of 
the nature and extent of its use. Such indicators
include population studies, criminal justice data,
laboratory data, drug treatment data, user
surveys, and anecdotal information.
2.1 Prevalence Survey Data
NACD & DAIRU (2003) – 
Drug Prevalence Survey
In October 2003, initial findings from the first 
Irish drug prevalence household survey were
published by the NACD and DAIRU13. This
general population survey found that 3% of the
adult population (aged 15-64) reported using
cocaine (powder) in their lifetime. After cannabis
(18%), magic mushrooms (4%) and ecstasy (4%),
cocaine was the next most commonly used illegal
drug (see Figure 2.1.1).
Male respondents reported more than double
the rate of lifetime cocaine use (4.3%) than
females (1.7%). The highest level of cocaine use
reported was among 15-24 year olds who
reported a lifetime prevalence rate of 5.1%,
followed by rates of 4.2 % among 25-34 year olds
and 2.7% among 35-44 year olds. Minimal rates
of cocaine use were reported by those aged 45
and over.
In terms of more recent levels of cocaine use 
(i.e. in the year prior to the survey), 15-34 year
olds reported cocaine as the third most used
illegal drug (2%) after cannabis (8.7%) and 
ecstasy (2.2%) (see Figure 2.1.2 page 11).
In terms of current use (i.e. in the month prior 
to the survey) among 15-34 year olds cocaine 
was the second most reported drug used at 0.7%
after cannabis (4.4%) (see Figure 2.1.2 page 11).
A very small number of respondents reported 
the use of crack. Less than one percent (0.5%) of
young adults aged between 15-34 reported ever
using crack. In the year prior to the survey, 0.2%
of respondents in this age group reported using
this drug. However, no current use (i.e. in the
previous month) was reported (see Figure 2.1.2
page 11).
SLÁN (2002) and ESPAD (1999)
Surveys
Two other population surveys have been
conducted in Ireland which included questions
about the use of cocaine. In 1998, the SLÁN survey
of health and lifestyle behaviours in the general
population, found 1.8% of males and 0.6% of
female adults aged 18–64 had used cocaine in the
previous year. However, this rate was almost three
times as high (3.4%) in the 18-24 year age group.14
In 2002, the rate among males and females who
had used cocaine in the previous year had
increased to 3.0% and 1.9% respectively.15
The 1998 SLÁN survey also included results from
the HBSC survey of Irish health behaviours in
school aged children (9-17 years). The findings
from this survey show that 2.3% of respondents
reported they had ever used cocaine, and 1.7%
reported they had used cocaine in the previous
month.17
In 1999, the ESPAD (European School Survey
Project on Alcohol and other drugs) survey
reported 2% of the school children (aged 16
years) surveyed reported ever having used
cocaine and crack.18
Indicators of Trends in Cocaine Use 
Chapter 2
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Figure 2.1.1 
Lifetime Prevalence of Illegal Drugs, 
Republic of Ireland 
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2.2 Police and Criminal 
Justice Data
Misuse of Drugs Act Offences
Garda Síochána data on Offences under the
Misuse of Drugs Act (MDA)19 show a substantial
increase in offences relating to cocaine
throughout the 1990s from 11 cases recorded in
1990 to almost 300 cases in 2001 (see Table 2.2.1).
Nonetheless, cocaine related offences remain
relatively small (3% of all MDA offences in 2001)
compared to offences for other drugs. The
majority of MDA offences continue to be for
cannabis (60% approx.) and ecstasy (27%
approx.). 
MDA offences relating to cocaine were recorded
predominantly in the Dublin Metropolitan Region
(62%) with a significant number (17%) recorded 
in the Southern Region (see Table 2.2.2).
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Table 2.2.1 
Number of Misuse of Drugs Act Offences by Drug Type
Year Cocaine Amphetamine Heroin Cannabis Resin Ecstasy
1990 11 n/a 71 1,413 –
1991 7 n/a 45 2,354 45
1992 11 n/a 91 2,643 3
1993 15 n/a 81 2,895 66
1994 15 n/a 230 2,848 261
1995 30 n/a 296 2,209 645
1996 42 n/a 432 1,441 340
1997 97 n/a 564 2,096 475
1998 88 n/a 789 1,749 439
1999 169 464 887 3,281 1,023
2000 180 391 730 4,031 2,086
2001 297 207 908 4,053 1,845
Source: Garda Síochána
Figure 2.1.2 
Prevalence of Cocaine and Crack Use, Ireland 
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It should be noted, however, that increases in
MDA offences may be seen to reflect increased
Garda activity and resources as well as indicating
increased drug use in the population.
Seizures
It is difficult to interpret trends from seizure data20
as the quantities seized vary a great deal from
year to year (see Tables 2.2.4 and 2.2.5). Again,
seizures may reflect level of Garda Síochána 
and Customs and Excise activity rather than the
extent of illicit drugs in circulation. While seizures
of cocaine by the Garda Síochána have fluctuated
throughout the 1990s, they have remained
relatively consistent accounting for 3% of the
total number of seizures.
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Table 2.2.3 
Number of Drug Seizures by Garda Síochána
Year Cocaine Amphetamine Heroin Cannabis Resin Ecstasy (MDMA)
1999 213 467 767 4,322 1,063
2000 206 169 598 4,401 1,846
2001 300 162 802 5,960 1,482
Source: Garda Síochána
Table 2.2.4 
Quantity and Number of Cocaine Seizures by
Garda Síochána
Year Quantity Number % of Total
of Cases Seizures
1997 11,020g 157 n/a
1998 333,167g 151 n/a
1999 85,554g 213 3%
2000 18,041g 206 3%
2001 5,325g 300 3%
Source: Garda Síochána
Garda Divison 1999 2000 2001
Eastern 9 19 14
Dublin Metropolitan 126 120 184
Northern 4 2 13
South Eastern 6 11 18
Southern 10 21 51
Western 14 7 17
All regions 169 180 297
As a percentage of all 
MDA offences 2.3% 2.14% 3%
Source: Garda Síochána
Garda Divisions
Eastern (Carlow/Kildare, Laois/Offaly,
Longford/Westmeath, 
Louth/Meath)
Northern (Cavan/Monaghan, Donegal,
Sligo/Leitrim)
South Eastern (Tipperary, Waterford/Kilkenny,
Wexford/Wicklow)
Southern (Cork, Kerry, Limerick)
Western (Clare, Galway West, Mayo,
Roscommon/Galway East)
Table 2.2.2 
Misuse of Drugs Act Offences Relating to Cocaine by Garda Division where Proceedings Commenced
Table 2.2.5
Quantity and Value of Cocaine Seized by
Customs and Excise
Cases Quantity Value
(kgs)
1999 n/a 27.20 £IR3,359,500
2000 n/a 11.81 £IR1,183,000
2001 3 .01 €1,016
Source: Customs and Excise
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2.3 Laboratory Data
The Drug Analysis Laboratory of the Drug
Treatment Centre Board (Trinity Court) reported
an increase in the number of cocaine positive
urine samples. An increase in cocaine positive
urine samples was reported for the first six
months of 2001 compared to 2002. It should be
noted that these tests are predominantly carried
out on drug users in treatment and are not
representative of the general population. In
addition, it should be noted that the data refers
to the number of tests conducted rather than the
number of individuals tested.
The Medical Bureau of Road Safety reported 
that blood and urine specimens of drivers taken
by the Garda Síochána found 6 samples testing
positive for cocaine from a total of 78 samples 
in 2000. In 2001, 10 samples were confirmed
positive from the 131 specimens taken.
2.4 Drug Treatment Data
Data from the National Drug Treatment Reporting
System (NDTRS) provides information on all
individuals receiving treatment during a given
year (all treatment contacts/cases) and on a sub
group of these who received treatment for the
first time (new treatment contacts/cases). This
data is representative of those who receive
treatment for their problem drug use rather than
the general drug using population.
Table 2.4.1 shows the main problem drugs
reported by all and new treatment contacts in
2000. The vast majority of contacts reported
opiates to be their main problem drug (76% of 
all cases and 47% of new cases), while just over
1% of all cases and 1.7% of new cases cited
cocaine as their main problem drug.
Benzodiazepines were the most frequently
reported second problem drug (18%) compared
to 7% who reported cocaine (see Table 2.4.2). 
For new cases, cannabis was the most frequently
reported second problem drug (18%) compared
to cocaine (3.6%). 
When the data for those citing cocaine as a
problem drug is examined over time (see Table
2.4.3), small but increasing numbers of all and
new treatment contacts are seen to report
cocaine as their main problem drug. However, the
number and proportion of all treatment contacts
reporting cocaine as their second problem drug
increased substantially between 1996 and 2000.
Of those in treatment during 2000 and reporting
cocaine as their main problem drug (n=78), 
53 (67.9%) reported snorting while 14 (17.9%)
reported injecting the drug. In contrast, of those
who stated cocaine was their secondary drug of
misuse (n=502), almost half (47.5%) reported
injecting while one third (33.6%) reported snorting
the drug (unpublished data from the NDTRS).
In 2000, over half of the cases (54%) presenting
with cocaine as their main problem drug and the
majority (88%) of those reporting cocaine as their
second problem drug were treated in the Eastern
Regional Health Authority (ERHA) area (see Table
2.4.4). Treatment contacts living in ERHA and
reporting cocaine as their secondary problem
drug were more likely to report that heroin was
their main problem drug than their counterparts
living outside the ERHA area (96.0% versus 48.3%).
This may reflect a different pattern of treatment
seeking (and possibly use) for cocaine in Dublin,
Wicklow and Kildare when compared with the rest
of Ireland (unpublished data from the NDTRS).
Table 2.3.1
Urinanalysis – Drug Treatment Centre Board
Year Number N. tested % tested 
of tests positive positive
(N) for cocaine for cocaine
2001 (Jan-Jun) 84,993 3,015 3.5%
2002 (Jan-Jun) 84,881 5,045 6.0%
Source: Drug Treatment Centre Board
Table 2.3.2
Urinanalysis – Medical Bureau of Road Safety
Year Number of N. tested % tested 
specimens positive positive 
tested (N) for cocaine for cocaine
2000 78 6 7.7%
2001 131 10 7.6%
Source: Medical Bureau of Road Safety
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Table 2.4.3
Number of Treatment Contacts where Cocaine was cited as the Main or Second Problem Drug Used
(corrected numbers), 1996-2000
1996 1997 1998 1999 2000
All treatment contacts 4,865 4,910 6,043 6,443 6,994
Cocaine main problem drug 25 42 85 58 78
Cocaine secondary problem drug 121 196 292 444 502
First treatment contacts 2,041 1,528 1,625 1,852 1,981
Cocaine main problem drug 17 22 32 28 33
Cocaine secondary problem drug 50 48 60 86 71
Source: DMRD (2002) Occasional Papers No.s 1-8, except for 2000 figures which are unpublished NDTRS data
Table 2.4.2
Secondary Problem Drug Reported by All and New Cases in Treatment, 2000
All cases New cases
Drug Number Percentage Number Percentage
No secondary drug 2,068 29.6 583 29.5
Opiates 893 12.8 146 7.4
Cocaine 502 7.2 71 3.6
Ecstasy 566 8.1 317 16.0
Amphetamines 140 2.0 83 4.2
Benzodiazepines 1,258 18.0 147 7.4
Volatile Inhalants 21 0.3 15 0.8
Cannabis 1,052 15.0 361 18.3
Other substances 126 1.8 48 2.4
Alcohol 368 5.3 207 10.5
Total number of cases 6,994 1,978
Source: DMRD (2003) Occasional paper No. 9
Table 2.4.1
Main Problem Drug Reported by All and New Cases in Treatment, 2000
All cases New cases
Drug Number Percentage Number Percentage
Opiates 5,333 76.3 934 47.2
Cocaine 78 1.1 33 1.7
Ecstasy 290 4.1 208 10.5
Amphetamines 30 0.4 19 1.0
Benzodiazepines 99 1.4 25 1.3
Volatile Inhalants 42 0.6 31 1.6
Cannabis 1,081 15.5 703 35.5
Other substances 41 0.6 25 1.3
Total number of cases 6,994 1,978
Source: DMRD (2003) Occasional paper No. 9
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Table 2.4.4
Number of Treatment Contacts where Cocaine was cited as the Main or Second Problem Drug Used
(corrected numbers), 1996-2000
1996 1997 1998 1999 2000
All cases – Cocaine main problem drug
Eastern Regional Health Authority* 20 30 61 39 41
Mid Western Health Board 1 4 13 3 12
South Eastern Health Board 3 5 8 6 8
Southern Health Board 0 3 3 9 8
Other Health Board Areas** 1 0 0 1 7
Total 25 42 85 58 76
All cases – Cocaine second problem drug
Eastern Regional Health Authority* 110 177 272 406 444
Mid Western Health Board 3 9 9 18 12
South Eastern Health Board 4 6 5 6 20
Southern Health Board 1 4 5 5 17
Other Health Board Areas** 3 0 1 9 11
Total 121 196 292 444 504
New cases – Cocaine main problem drug
Eastern Regional Health Authority* 14 15 26 18 17
Mid Western Health Board 1 1 1 1 6
South Eastern Health Board 2 4 3 4 4
Southern Health Board 0 2 2 5 2
Other Health Board Areas** 0 0 0 0 4
Total 17 22 32 28 33
New cases – Cocaine second problem drug
Eastern Regional Health Authority* 43 45 51 71 41
Mid Western Health Board 3 9 9 18 6
South Eastern Health Board 2 1 3 1 11
Southern Health Board 1 2 4 3 7
Other Health Board Areas** 2 0 0 3 6
Total 51 57 67 96 71
Source: DMRD (2002) Occasional Papers No.s 1-8, except 2000 figure for ERHA which is unpublished NDTRS data
* Figures for 1999 and earlier relate to the Eastern Health Board area which was replaced by ERHA in 2000.
** Due to the small number of cases reported in the Midland, North Eastern, North Western, and Western Health Boards 
a total figure for these areas is provided.
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2.5 Research Studies of Cocaine Use
Mayock (2001) – Exploratory Study 
of Cocaine Use in Ireland
In a study conducted for the Health Research
Board, Mayock (2001) used available indicators of
drug use and the perceptions of key informants
and drugs workers as the basis for an exploratory
study of cocaine use.
The study found strong indicators of increased
availability and use of cocaine. In addition, data
from in depth interviews with ten recreational
cocaine users reported an increased visibility 
of cocaine on the club and pub scenes, a
development which was regarded as recent.
While the study found no systematic evidence 
of widespread cocaine use, the broad picture
uncovered was one of increased likelihood of
cocaine use among certain groups of recreational
poly drug users.
The author also noted signs of increased cocaine
use among opiate users who come from more
disadvantaged urban areas, particularly within
Dublin City. However, the nature of cocaine use
was likely to differ substantially between
problematic opiate drug users and recreational
drug users. In addition, routes of administration
were seen to vary between the two groups. For
example, recreational users interviewed for the
research ingested cocaine intranasally or orally,
and did not consider their drug consumption as
damaging or problematic. None of this group
had been exposed to crack cocaine and did not
consider using cocaine in this form.
UISCE (2002) – Survey of Cocaine Users
A survey of 100 cocaine users from the Dublin area
was conducted by UISCE (Union for Improved
Services, Communication and Education) for the
NACD during November 2002. The sample
chosen was purposive in that the interviewers used
their networks and contacts to approach people
they thought likely or knew to be cocaine users
and completed face to face interviews with those
who agreed.
Just over half (55%) of those surveyed were
female. The average (mean) age of respondents
was 30 years old; almost half (46%) of the
respondents were in the 25-34 year age group.
Over half (58%) of the sample reported injecting
cocaine, almost as many (55%) said they snorted
cocaine, while over a third (37%) said they
smoked cocaine/crack. The range and overlap of
methods by which the drug is used has risk
implications for HIV and Hepatitis C infection and
the harm reduction needs of users.
Among those surveyed, the average age of first
use of cocaine was twenty-one years of age;
regular use of the drug began somewhat later, on
average at 25 years of age. Female respondents
were younger than their male counterparts both
when they first used the drug (over a quarter
were under 18 years of age) and also when they
began to use the drug regularly.
The majority of the respondents were weekly
users with almost half (48%) using on a weekly
basis, approximately four times a week. Forty
percent of the respondents used cocaine on a
daily basis, on average four times a day. Twelve
percent used cocaine on a monthly basis, on
average two to three times per month.
The respondents reported high levels of poly
drug use. Approximately three quarters of those
surveyed also used alcohol (71%) and cannabis
(74%). Approximately half used benzodiazepines
(54%) and methadone (49%) while less than half
(43%) also used heroin. There were some gender
differences in the range of drugs used. The 
male cocaine users reported more alcohol,
methadone and heroin use than the females,
while a higher percentage of women reported
using antidepressants and amphetamines along
with cocaine.
Figure 2.5.1 
UISCE Survey – Percentage of Respondents
Using Other Drugs
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The contrast between the men and women in 
the sample shows some interesting trends. The
women in the sample were younger both when
they first used the drug and when they started
using the drug regularly. More women were
injecting than men but the women used less
frequently and fewer regarded their cocaine use
as a problem.
Almost half of the respondents (46%) said they
were receiving drug treatment at the time of 
the interview. Forty-three percent said they were
receiving treatment for their problematic use 
of heroin. Almost three quarters (74%) of those
currently in treatment for their heroin use
reported seeking treatment for their cocaine use.
A high proportion of the respondents (60%) felt
their cocaine use was problematic, almost all of
these (98%) had experienced changes in behaviour
since using cocaine. However, less than a third of
these had sought treatment.
Almost half (45%) of the respondents had looked
for information on using cocaine, both those who
regarded their drug use problematic and those
who didn’t, while almost a quarter (22%) had
sought treatment for their cocaine use.
The findings on treatment and information
requirements suggest different needs for this
group. While many of the respondents felt their
cocaine use was a problem, they were more likely
to seek information than treatment. The low
numbers of people seeking treatment may reflect
the perceived lack of treatment for cocaine users.
However, as the respondents were primarily poly
drug users the implications are that treatment
services may need to address generic addiction
issues rather than focus service delivery on a
particular type of drug.
Merchants Quay Ireland (2003) –
Survey of Cocaine Users
During February 2003, Merchants Quay Ireland
conducted a survey, for the NACD, of 100 clients
presenting at their Contact Centre who had used
cocaine/crack in the previous year.
Over three quarters (n=79) of those surveyed
were male and twenty-one were female. The age
range of those surveyed was between 19 – 48
years while the average (mean) age was 29 years.
Almost half of the respondents (49%) were from
Dublin’s inner city. Over half (53%) of those
interviewed were homeless (i.e. defined as those
who reported living in a hostel, a B&B, a squat,
staying with friends or sleeping rough). The vast
majority of clients were unemployed (n=90), nine
were in paid employment and one person was on
a CE Scheme.
Among the 100 respondents, 95% had used
cocaine powder in the last year and 40% had
used crack cocaine – 60% had used cocaine
powder only, 5% had used crack cocaine only,
while over a third (35%) had used both. Of the 40
respondents who had used crack cocaine in the
last year, half had bought it as rocks (n = 20) while
16 had washed it themselves (40%).
The average (mean) age of first use of cocaine was
22 years, similar to the first age of crack use at 23
years. However, almost half (n=44) of cocaine users
began using before they were 20 years of age,
compared to a third (n=12) of crack users.
All of the respondents surveyed were poly drug
users i.e. currently using a number of (on average
four) illicit drugs. Heroin was the most common
primary drug for this group (59%) with a much
smaller number (17%) reporting cocaine as their
primary drug. Overall, 83% of the respondents
reported using heroin; three-quarters were using
methadone, this was prescribed for most (82%,
n=61); two thirds reported using benzodiazepines
(65%); and over half (52%) reported alcohol use.
Figure 2.5.2 
Merchants Quay Ireland Survey – Percentage 
of Respondents Using Other Drugs
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Given that the Contact Centre mainly targets
intravenous drug users, it was not surprising that
the vast majority of cocaine users (82%) reported
injecting cocaine while 15% reported snorting
and 3% (n=1) smoking. The majority of those who
injected cocaine (59%, n=46) injected it by itself,
while 41% (n=32) mixed it with heroin (i.e. as a
speedball). Two-thirds (n=26) of crack users
reported smoking, while 30% reported injecting
crack. These very high rates of injecting cocaine,
crack and ‘speedball’ indicate particularly high
levels of risk behaviour among this group.
The frequency of cocaine use among the
respondents was not overly high, reflecting the
range of other drugs used by this cohort. Almost
half (49%) of the respondents reported weekly use
of cocaine while twenty per cent reported daily
use. A third (33%) reported weekly use of crack
while 5% reported daily use. However, 45% (n=18)
of those who used crack and 23% (n=22) of
cocaine users had not used in the last month
indicating infrequent or binge use (repetitive use
over a short period of time) for this cohort. Almost
three-quarters (n=73) of the respondents describe
their use as binge use: an issue which has high
risk implications and which poses difficulties for
the agencies dealing with this group.
The 78 respondents who injected cocaine were
asked if they had experienced any difficulties
resulting from their drug injecting. Sixteen (21%)
had experienced accidental overdoses. Over
one-third (37%, n=29) reported scarring/bruising
while approximately a quarter experienced dirty
hits (27%, n=21) and abscesses (24%, n=19).
Other complaints included thrombosis,
palpitations and blood clots. It is worth noting
however, that 87% of those who injected cocaine
were currently also using heroin, so it is difficult
to conclude whether the difficulties experienced
were due to intravenous heroin or cocaine use.
Approximately half of the respondents noticed
they had become more depressed (54%) and
more anxious (50%) since using cocaine/crack, 
A large number reported breathing difficulties
(45%) and a third (34%) said they had become
more confused. Other changes in behaviour
noticed by respondents included paranoia (13%),
aggressiveness (5%), suicidal feelings (2%), anger
(2%), mood swings (2%), hallucinations (1%), and
agitation (1%).
However, despite these issues, two-thirds (66%) of
the respondents felt that their cocaine use was
not problematic and only 12% of the respondents
had sought treatment for their cocaine use.
Those who had sought treatment for cocaine
were slightly older (on average 32 years); no
client younger than 25 had ever sought treatment
for cocaine. Among those who perceived their
cocaine/crack use as problematic, only 16% (n=5)
had sought treatment for their cocaine/crack use.
Indeed, many respondents reported the futility of
seeking treatment for cocaine/crack use due to
the lack of a pharmacological substitute for its
use; as exists for the treatment of opiate misuse.
A large proportion of the respondents, almost
two-thirds (65%), were currently on methadone
maintenance programmes, while the vast majority
of respondents (92%) were in contact with needle
exchanges, just over a fifth (21%) were attending
drug counselling and 13% were going to NA
meetings.
The extent of poly drug use among the
respondents, and in particular among those
receiving treatment for heroin addiction, has
implications for services and their capacity to
respond to these clients.
2.6 Anecdotal Information
Anecdotal reports suggest that the increase 
in cocaine use has been across the general
population not just among existing problem drug
users or confined to certain urban areas. Reports
of an increased level of cocaine use in the pub
and club scenes are thought to be related to
greater availability, cheaper price and as a
substitute for ecstasy which appears to have
become less fashionable and less popular due 
to reports of poor and fluctuating quality.
Sources indicate that cocaine powder is being
sold for between €30-40 per ‘1/2 gram’ (usually 
a smaller amount is involved). A gram of cocaine
would give users between 5-10 lines for snorting
which could last two people anything from a
couple of hours to a whole night, depending 
on their tolerance, appetite for the drug and 
its strength.
Anecdotal information about the use and sale 
of crack cocaine is patchier, one report told of 
it being sold for €50 for a rock which would be
sufficient for about 5 smokes.
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In 2002, Citywide Drugs Crisis Campaign
facilitated a meeting of community, voluntary 
and statutory sector representatives to discuss
‘Cocaine Use in our Communities’. Attendees 
at the meeting identified two distinct groups:
cocaine users who have never had involvement 
in heroin use, and existing heroin users many of
whom are also clients of drug services.
Attendees from drug treatment services raised
concerns about the number of clients who 
are co-dependent on heroin and cocaine and 
the implications this had for their stability in
treatment. Attendees also reported that the new
cocaine users perceived the drug as clean and
acceptable with minimal health implications, and
were attracted by the perceived effects such as
the absence of hangovers and an increase in sex
drive. The meeting also reported that the drug is
readily available and acceptable, especially in
pubs in a way that heroin has never been.
13 DAIRU - The Drug and Alcohol Information and
Research Unit in Northern Ireland
14 Moran et al., 2001
15 SLÁN and HBSC, 2002
16 Moran et al., 2001
17 Moran et al., 2001
18 Hibbell et al., 2000
19 An Garda Síochána, 2002
20 An Garda Síochána, 2002; Revenue Commissioners, 2002
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The challenge for drug treatment services is to
turn what has historically been a predominantly
opiate focused treatment system into one that is
capable of meeting the needs of cocaine misusers.
Without the incentive of a substitute drug to offer,
such as methadone, a key task will be to attract
problem cocaine users into services and retain
them long enough to achieving lasting change. 
3.1 Review of Treatment Literature
The international literature demonstrates that 
there is no recognised pharmacotherapy 
(chemical treatment of dependence) for cocaine
dependence.22 However, findings from a preliminary
trial using Buprenorphine and Disulfiram (Antabuse)
with heroin and cocaine dependent subjects do
suggest that this combined therapy can have an
effect on the use of cocaine.23 The use of
Methadone and Disulfiram for heroin and cocaine
dependent subjects also showed promising results
even when alcohol use was controlled for.24
Disulfiram used with psychotherapies for treating
cocaine and alcohol dependence in patients was
found to contribute to reduced cocaine use over
the long term.25 However, it is recommended that
other measures such as psychosocial support
should be available to the individual whilst they are
receiving pharmacotherapy.26
In the UK, the National Treatment Outcome
Study (NTORS) has shown that about one third of
heroin users at intake were also using crack
cocaine. At the four and five year follow up, use
of crack cocaine had more than halved. However,
for the heroin users who did not use crack
cocaine at intake, at least one quarter were using
at follow up. This is of particular concern and has
implications for the management of poly drug
use in those who present to treatment services.27
These findings indicate the importance of
managing secondary drug misuse and engaging
proactively in relapse prevention.
Once they start treatment, clients tend to stay
longer and respond better if they feel that their
concerns are being positively addressed and that
their key worker is empathic and understanding,
underlining the crucial role workers play in
motivating and retaining clients.28
Counselling, both individual and group therapy 
is effective in the management of cocaine
dependence. Recognised psychotherapies
delivered by professional psychologists perform
no better than well- structured drug counselling.
In the USA, cognitive-behavioural approaches
have a relatively large and positive evidence
base. Group therapy using these approaches 
has been found to be as effective as individual
therapy. Both individual and group therapy is
effective in relapse prevention.29
Retention in treatment is influenced by
demographic factors such as age, education and
employment. In addition, the severity of cocaine
use on entry and the presence of a psychiatric
disorder is seen to impact negatively on
treatment retention.30
Providing further training to staff whilst caring 
for clients does not impact negatively on
outcomes. Mental health trainees were taught 
to apply effective Network Therapy (a cognitive
behavioural approach) for effective substance
abuse management. Their patients fared as well
as those receiving treatment with experienced
therapists.31
There is little understanding of how to prompt
initial contact with treatment services, but once
contact is made, rapid intake, proactive
reminders, and practical help with attendance
have improved treatment uptake rates.32 Cocaine
users offered treatment within 24 hours are four
times more likely to attend for the appointment
than those offered treatment later. Initial
attendance at treatment is not influenced
significantly by client and situational variables 
but by delay between the initial phone contact
and the appointment offered.33
Cocaine users with complex needs such as
homelessness and mental health issues showed
satisfactory levels of abstinence (69% of 340
subjects) by combining peer leadership and
professional support in a day programme.34
Self-help groups are also effective. Cocaine users
who have previous experience of drug treatment
and severe cocaine use were found to be the
most frequent attendees.35
Treatment Approaches
Chapter 3
A
n
 O
ve
rv
ie
w
 o
f 
C
o
ca
in
e
 U
se
 i
n
 I
re
la
n
d
N
A
C
D
21
Drug-free psychosocial interventions such as
counselling, provided on a non-residential basis,
are the most cost-effective options for clients
with few complicating problems.36
Cost benefit analysis of long term residential
(LTR) and out-patient drug free (ODF) treatments
for cocaine dependent patients from DATOS
(USA longitudinal treatment study) showed that
both patients treated in LTR and ODF showed
reductions in costs of crime before and after
treatment. Highest levels of crime were
associated with LTR patients before treatment
yet, they showed the highest level of reductions
in cost of crime after treatment. This shows that
treatment provides significant returns on
investment.37
Harm reduction messages need to be targeted 
at cocaine users also. Young people are often
oblivious to the harms and how to minimise 
them when using cocaine.38 Harm reduction
approaches are very effective and have not led 
to an increase in injecting drug use.39
Patients who receive optimal therapy depending
on the severity of their cocaine use have
decreased their cocaine use by up to 85%. Long
term residential therapy was most effective for
patients with severe and complex problems
whilst outpatient therapy was effective for those
with moderate problems.40
Clients with multiple needs tend to benefit from
intensive residential rehabilitation and (if they stay
long enough) do better there than in community-
based drug counselling. However, for many clients
intensive rehabilitation programmes can be
provided just as effectively on a day-care basis.41
Alternative therapies are increasingly popular 
and some early findings are showing that when
auricular acupuncture is used in addition to 
other interventions as part of a comprehensive
programme, patients show decreased cocaine
use and higher levels of abstinence. Alternative
therapies could play an important role in
retaining patients in treatment.42
In summary, our review of treatment literature
found the following to be effective:
 Individual drug counselling
 Group therapy/counselling
 Self help groups
 Peer leadership
 Provision of early appointments
 No delays in providing treatment
 Outpatient programme for moderate
problems
 Residential programme for complex and
severe problems
 Combined pharmacotherapies in conjunction
with other interventions
22 Farrell et al., 2002
23 George et al., 2000; Weiss and O’Leary, 2000
24 Petrakis et al., 2000; Weiss and O’Leary 2000
25 Carroll et al., 2000
26 Farrell et al., 2002
27 Gossop et al., 2002
28 Whitton and Ashton, 2002
29 CritsChristoph et al., 2001; Schmitz et al., 1997
30 Siqueland et al., 2002a; Siqueland et al., 2002b
31 Galanter et al., 1997
32 Whitton and Ashton, 2002
33 Festinger et al., 1995 and 2002
34 Galanter et al., 1998
35 Weiss et al., 2000
36 Flynn et al., 1999
37 Flynn et al., 1999
38 Boys et al., 2002 
39 vanAmeijden and Coutinho 2001; Magura 1998
40 NIDA 1999
41 Whitton and Ashton 2002
42 NIDA 2000
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It is clear from the research that people who start
using cocaine do not consider the harmful effects.
It is perceived as a safe drug that does not lead 
to dependency in the same way that other drugs
such as heroin do. The harm of mixing alcohol
and cocaine use on the same occasion add
significant risks and is little understood by cocaine
users. Drug prevention approaches in Ireland are
consistent with best practice internationally and
there should be continued investment in this
area43. Approaches that emphasise personal and
social development, stress social skills and
enhance decision-making in school based and
community programmes can be effective44.
The perception that cocaine is a safe drug has
implications for the levels of risk behaviour
associated with injecting, with the sharing of
snorting and smoking equipment to administer
the drug, and with combining cocaine use with
alcohol use.
The regional spread of cocaine users in both
treatment data and Garda Síochána data
indicates that the use of cocaine is not just 
a Dublin phenomenon.
To date, a small number of treatment contacts
have presented to services with cocaine as their
primary drug of misuse – approximately 1% of all
contacts. This would seem to suggest that primary
cocaine users do not perceive themselves as
requiring treatment for their drug use, or, that 
that they perceive existing treatment services 
as being inappropriate to their needs.
The level of poly drug use noted in both the
treatment population and the survey of cocaine
users represents a challenge for drug education,
prevention, treatment, and harm reduction services. 
For drug treatment services the challenge will be
to turn what has historically been a predominantly
opiate focused system into one that meets the
needs of cocaine and poly drug misusers. Without
the incentive of a substitute drug to offer, such as
methadone, a key task will be to attract cocaine
users into services and retain them long enough
to achieving lasting change. 
43 Morgan, 2001
44 Morgan, 2001
Findings and Implications
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